Fetal cardiac arrhythmia detection and in utero therapy

Nature Reviews Cardiology

Volumn 7, Issue 5, 2010, Pages 277-290

  Strasburger, Janette F ^a   Wakai, Ronald T ^b  

^a Children's Hospital of Wisconsin ^*  (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DEXAMETHASONE; DIGOXIN; FLECAINIDE; LA ANTIBODY; LIDOCAINE; MAGNESIUM SULFATE; PROCAINAMIDE; PROPRANOLOL; RO ANTIBODY; SOTALOL; STEROID; TERBUTALINE;

ATRIOVENTRICULAR BLOCK; CHANNELOPATHY; CLINICAL TRIAL; DOPPLER ECHOCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; FETUS; FETUS DEATH; FETUS DISEASE; FETUS HEART RATE; FETUS HYDROPS; FETUS MORTALITY; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART VENTRICLE TACHYCARDIA; HUMAN; LOADING DRUG DOSE; LONG QT SYNDROME; MAGNETOCARDIOGRAPHY; NEWBORN DEATH; PLACENTAL TRANSFER; PR INTERVAL; PRENATAL DIAGNOSIS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; REENTRY TACHYCARDIA; REVIEW; SINUS BRADYCARDIA; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES;

ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FETAL DISEASES; FETAL HEART; FETAL MONITORING; FOLLOW-UP STUDIES; GESTATIONAL AGE; HEART CONDUCTION SYSTEM; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; ULTRASONOGRAPHY, PRENATAL;

EID: 77951735572     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.32     Document Type: Review

References (116)

1. Cuneo, B. F. et al. Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome. Am. J. Cardiol. 91, 1395-1398 (2003).
2. Hamada, H. et al. Prenatal diagnosis of long QT syndrome using fetal magnetocardiography. Prenat. Diagn. 19, 677-680 (1999).
3. Horigome, H., Iwashita, H., Yoshinaga, M. & Shimizu, W. Magnetocardiographic demonstration of torsade de pointes in a fetus with congenital long QT syndrome. J. Cardiovasc. Electrophysiol. 19, 334-335 (2008).
4. Hosono, T., Shinto, M., Chiba, Y., Kandori, A. & Tsukada, K. Prenatal diagnosis of fetal complete atrioventricular block with QT prolongation and alternating ventricular pacemakers using multi-channel magnetocardiography and current-arrow maps. Fetal Diagn. Ther. 17, 173-176 (2002).
5. Miller, T. E. et al. Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome. Circulation 109, 3029-3034 (2004).
6. Beery, T. A., Shooner, K. A. & Benson, D. W. Neonatal long QT syndrome due to a de novo dominant negative hERG mutation. Am. J. Crit. Care 16, 412-416 (2007).
7. Baruteau, A.-E. & Study, A. F. M. Non-immune isolated atrioventricular block in childhood: a French multicentric study [Abstract]. Heart Rhythm 39 (Suppl.), AB19-AB31 (2009).
8. Tester, D. J., McCormack, J. & Ackerman, M. J. Prenatal molecular genetic diagnosis of congenital long QT syndrome by strategic genotyping. Am. J. Cardiol. 93, 788-791 (2004).
9. Zhao, H., Strasburger, J. F., Cuneo, B. F. & Wakai, R. T. Fetal cardiac repolarization abnormalities. Am. J. Cardiol. 98, 491-496 (2006).
10. Dubin, A. M. et al. Congenital junctional ectopic tachycardia and congenital complete atrioventricular block: a shared etiology? Heart Rhythm 2, 313-315 (2005).
11. Rein, A. J. et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation 119, 1867-1872 (2009).
12. Rein, A. J. et al. Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 106, 1827-1833 (2002).
13. Wakai, R. T., Lengle, J. M. & Leuthold, A. C. Transmission of electric and magnetic fetal cardiac signals in a case of ectopia cordis: the dominant role of the vernix caseosa. Phys. Med. Biol. 45, 1989-1995 (2000).
14. Acherman, R. J. et al. Fetal bradycardia. A practical approach. Fetal Matern. Med. Rev. 18, 225-255 (2007).
15. [No authors listed]. ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management guidelines. Obstet. Gynecol. 114, 192-202 (2009).
16. Serra, v., Bellver, J., Moulden, M. & Redman, C. W. Computerized analysis of normal fetal heart rate pattern throughout gestation. Ultrasound Obstet. Gynecol. 34, 74-79 (2009).
17. Robinson, S. M., Wheeler, T., Hayes, M. C., Barker, D. J. & Osmond, C. Fetal heart rate and intrauterine growth. Br. J. Obstet. Gynaecol. 98, 1223-1227 (1991).
18. Beinder, E., Grancay, T., Menéndez, T., Singer, H. & Hofbeck, M. Fetal sinus bradycardia and the long QT syndrome. Am. J. Obstet. Gynecol. 185, 743-747 (2001).
19. Cuneo, B. F., Strasburger, J. F., Niksch, A., Ovadia, M. & Wakai, R. T. An expanded phenotype of maternal SSA/SSB antibodyassociated fetal cardiac disease. J. Matern. Fetal Neonatal Med. 22, 233-238 (2009).
20. Ozkutlu, S., Onderoglu, L., Karagoz, T., Celiker, A. & Sahiner, U. M. Isolated noncompaction of left ventricular myocardium with fetal sustained bradycardia due to sick sinus syndrome. Turk J. Pediatr. 48, 383-386 (2006).
21. Maeno, Y. et al. Prenatal diagnosis of sustained bradycardia with 1:1 atrioventricular conduction. Ultrasound Obstet. Gynecol. 21, 234-238 (2003).
22. Cuneo, B. F., Strasburger, J. F. & Wakai, R. T. Magnetocardiography in the evaluation of fetuses at risk for sudden cardiac death before birth. J. Electrocardiol. 41, 116.e1-116.e6 (2008).
23. Baruteau, A. E. & Schleich, J. M. Antenatal presentation of congenital long QT syndrome: a prenatal diagnosis not to be missed. Pediatr. Cardiol. 29, 1131-1132 (2008).
24. Beinder, E., Buheitel, G. & Hofbeck, M. Are some cases of sudden intrauterine unexplained death due to the long QT syndrome? Prenat. Diagn. 23, 1097-1098 (2003).
25. Schwartz, P. J. Stillbirths, sudden infant deaths, and long-QT syndrome: puzzle or mosaic, the pieces of the jigsaw are being fitted together. Circulation 109, 2930-2932 (2004).
26. Schwartz, P. J. et al. Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 338, 1709-1714 (1998).
27. Berg, C. et al. Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet. Gynecol. 26, 4-15 (2005).
28. Glatz, A. C. et al. Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J. Thorac. Cardiovasc. Surg. 136, 767-773 (2008).
29. Cuneo, B. F. Outcome of fetal cardiac defects. Curr. Opin. Pediatr. 18, 490-496 (2006).
30. villain, E., Marijon, E. & Georgin, S. Is isolated congenital heart block with maternal antibodies a distinct and more severe form of the disease in childhood? Heart Rhythm 2 (Suppl. 1), S45 (2005).
31. Lopes, L. M. et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation 118, 1268-1275 (2008).
32. Buyon, J. P. & Winchester, R. Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum. 33, 609-614 (1990).
33. Boutjdir, M. Molecular and ionic basis of congenital complete heart block. Trends Cardiovasc. Med. 10, 114-122 (2000).
34. Buyon, J. P. & Clancy, R. M. Dying right to live longer: positing apoptosis as a link between maternal autoantibodies and congenital heart block. Lupus 17, 86-90 (2008).
35. Buyon, J. P. Neonatal lupus syndrome. In Systemic Lupus Erythematosus, 4th edn (ed. Lahita, R. G.) 473 (Elsevier Academic, 1998).
36. Friedman, D. M. et al. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) study. Am. J. Cardiol. 103, 1102-1106 (2009).
37. Buyon, J. P., Clancy, R. M. & Friedman, D. M. Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat. Clin. Pract. Rheumatol. 5, 139-148 (2009).
38. Buyon, J. P., Clancy, R. M. & Friedman, D. M. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/fetal dyad at risk. J. Intern. Med. 265, 653-662 (2009).
39. Motta, M., Rodriguez-Perez, C., Tincani, A., Lojacono, A. & Chirico, G. Outcome of infants from mothers with anti-SSA/Ro antibodies. J. Perinatol. 27, 278-283 (2007).
40. Friedman, D. M. et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 117, 485-493 (2008).
41. Sonesson, S. E., Salomonsson, S., Jacobsson, L. A., Bremme, K. & Wahren- Herlenius, M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52 kD antibodies. Arthritis Rheum. 50, 1253-1261 (2004).
42. Zhao, H. et al. Electrophysiological characteristics of fetal atrioventricular block. J. Am. Coll. Cardiol. 51, 77-84 (2008).
43. Gardiner, H. M. et al. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies. Heart 93, 1454-1460 (2007).
44. Li, Z., Strasburger, J. F., Cuneo, B. F., Gotteiner, N. L. & Wakai, R. T. Giant fetal magnetocardiogram P waves in congenital atrioventricular block: a marker of cardiovascular compensation? Circulation 110, 2097-2101 (2004).
45. Costedoat-Chalumeau, N., Amoura, Z., villain, E., Cohen, L. & Piette, J. C. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res. Ther. 7, 69-73 (2005).
46. Nield, L. E. et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J. Am. Coll. Cardiol. 40, 796-802 (2002).
47. Pises, N. et al. Positive maternal anti-SSA/SSB antibody-related fetal right ventricular endocardial fibroelastosis without atrioventricular block, reversal of endocardial fibroelastosis. Prenat. Diagn. 29, 177-178 (2009).
48. Nield, L. E. et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105, 843-848 (2002).
49. Bazett, H. C. An analysis of the time-relations of electrocardiograms. Heart 7, 353-370 (1920).
50. Kussman, B. D., Madril, D. R., Thiagarajan, R. R., Walsh, E. P. & Laussen, P. C. Anesthetic management of the neonate with congenital complete heart block: a 16-year review. Paediatr. Anaesth. 15, 1059-1066 (2005).
51. Buyon, J. P. Dispelling the preconceived notion that lupus pregnancies result in poor outcomes. J. Rheumatol. 32, 1641-1642 (2005).
52. Stinstra, J. et al. Multicenter study of fetal cardiac time intervals using magnetocardiography. BJOG 109, 1235-1243 (2002).
53. Nakai, K. et al. Development of 64-channel magnetocardiography and clinical application [Japanese]. Rinsho Byori 54, 844-849 (2006).
54. Horigome, H. et al. Standardization of the PQRST waveform and analysis of arrhythmias in the fetus using vector magnetocardiography. Pediatr. Res. 59, 121-125 (2006).
55. Cuneo, B. F. et al. Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am. J. Cardiol. 100, 661-665 (2007).
56. Cuneo, B. F., Strasburger, J. F., Wakai, R. T. & Ovadia, M. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn. Ther. 21, 307-313 (2006).
57. Comani, S., van Leeuwen, P., Lange, S., Geue, D. & Gronemeyer, D. Influence of gestational age on the effectiveness of spatial and temporal methods for the reconstruction of the fetal magnetocardiogram. Biomed. Tech. (Berl.) 54, 29-37 (2009).
58. Menéndez, T. et al. Usefulness of magnetocardiography for the investigation of fetal arrhythmias. Am. J. Cardiol. 88, 334-336 (2001).
59. Strasburger, J. F. Prenatal diagnosis of fetal arrhythmias. Clin. Perinatol. 32, 891-912 (2005).
60. Skog, A., Wahren-Herlenius, M., Sundstrom, B., Bremme, K. & Sonesson, S. E. Outcome and growth of infants fetally exposed to heart blockassociated maternal anti-Ro52/SSA autoantibodies. Pediatrics 121, e803-e809 (2008).
61. Eronen, M. et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 106 (Pt 1), 86-91 (2000).
62. Moak, J. P. et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J. Am. Coll. Cardiol. 37, 238-242 (2001).
63. Fesslova, v. et al. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block. Cardiol. Young 19, 282-290 (2009).
64. Gregoratos, G. et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices- summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J. Am. Coll. Cardiol. 40, 1703-1719 (2002). (Pubitemid 35253652)
65. Srinivasan, S. & Strasburger, J. Overview of fetal arrhythmias. Curr. Opin. Pediatr. 20, 522-531 (2008).
66. Carpenter, R. J. Jr et al. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J. Am. Coll. Cardiol. 8, 1434-1436 (1986).
67. Walkinshaw, S. A., Welch, C. R., McCormack, J. & Walsh, K. In utero pacing for fetal congenital heart block. Fetal Diagn. Ther. 9, 183-185 (1994).
68. Kohl, T. et al. Fetoscopic direct fetal cardiac access in sheep: an important experimental milestone along the route to human fetal cardiac intervention. Circulation 102, 1602-1604 (2000).
69. Kikuchi, Y., Shiraishi, H., Igarashi, H., Chunfeng, L. & Yanagisawa, M. Cardiac pacing in fetal lambs: intrauterine transvenous cardiac pacing for fetal complete heart block. Pacing Clin. Electrophysiol. 18 (Pt 1), 417-423 (1995).
70. Dell'Orfano, J. et al. The monolithic fetal pacemaker: prototype lead design for closed thorax deployment. Pacing Clin. Electrophysiol. 26 (Pt 1), 805-811 (2003).
71. Assad, R. S. et al. New lead for in utero pacing for fetal congenital heart block. J. Thorac. Cardiovasc. Surg. 126, 300-302 (2003).
72. Wakai, R. T., Strasburger, J. F., Li, Z., Deal, B. J. & Gotteiner, N. L. Magnetocardiographic rhythm patterns at initiation and termination of fetal supraventricular tachycardia. Circulation 107, 307-312 (2003).
73. Naheed, Z. J., Strasburger, J. F., Deal, B. J., Benson, D. W. Jr & Gidding, S. S. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J. Am. Coll. Cardiol. 27, 1736-1740 (1996).
74. Ko, J. K., Deal, B. J., Strasburger, J. F. & Benson, D. W. Jr. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am. J. Cardiol. 69, 1028-1032 (1992).
75. Kannankeril, P. J., Gotteiner, N. L., Deal, B. J., Johnsrude, C. L. & Strasburger, J. F. Location of accessory connection in infants presenting with supraventricular tachycardia in utero: clinical correlations. Am. J. Perinatol. 20, 115-119 (2003).
76. Hahurij, N. D. et al. Accessory atrioventricular myocardial connections in the developing human heart: relevance for perinatal supraventricular tachycardias. Circulation 117, 2850-2858 (2008).
77. Johnson, W. H. Jr, Dunnigan, A., Fehr, P. & Benson, D. W. Jr. Association of atrial flutter with orthodromic reciprocating fetal tachycardia. Am. J. Cardiol. 59, 374-375 (1987).
78. Strasburger, J. F., Cheulkar, B. & Wichman, H. J. Perinatal arrhythmias: diagnosis and management. Clin. Perinatol. 34, 627-652 (2007).
79. Strasburger, J. F. et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109, 375-379 (2004).
80. Simpson, J. M. Fetal arrhythmias. Ultrasound Obstet. Gynecol. 27, 599-606 (2006).
81. Simpson, J. M., Maxwell, D., Rosenthal, E. & Gill, H. Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature. Ultrasound Obstet. Gynecol. 34, 475-480 (2009).
82. Maeno, Y., Hirose, A., Kanbe, T. & Hori, D. Fetal arrhythmia: prenatal diagnosis and perinatal management. J. Obstet. Gynaecol. Res. 35, 623-629 (2009).
83. Cuneo, B. F. & Strasburger, J. F. Management strategy for fetal tachycardia. Obstet. Gynecol. 96, 575-581 (2000).
84. Cuneo, B. F. Treatment of fetal tachycardia. Heart Rhythm 5, 1216-1218 (2008).
85. Oudijk, M. A. et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 101, 2721-2726 (2000).
86. D'Alto, M. et al. The challenge of fetal dysrhythmias: echocardiographic diagnosis and clinical management. J. Cardiovasc. Med. (Hagerstown) 9, 153-160 (2008).
87. Jouannic, J. M. et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat. Diagn. 23, 152-156 (2003).
88. van Leeuwen, P. et al. Effect of prenatal antiarrhythmic treatment on cardiac function in a twin pregnancy. Pacing Clin. Electrophysiol. 31, 1213-1217 (2008).
89. Fish., F. A., Gillette, P. C. & Benson, D. W. Jr. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J. Am. Coll. Cardiol. 18, 356-365 (1991).
90. Fenrich, A. L. Jr, Perry, J. C. & Friedman, R. A. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy. J. Am. Coll. Cardiol. 25, 1195-1198 (1995).
91. Parilla, B. v., Strasburger, J. F. & Socol, M. L. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am. J. Perinatol. 13, 483-486 (1996).
92. Weiner, C. P. & Thompson, M. I. Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am. J. Obstet. Gynecol. 158 (Pt 1), 570-573 (1988).
93. Hallak, M., Neerhof, M. G., Perry, R., Nazir, M. & Huhta, J. C. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy. Obstet. Gynecol. 78 (Pt 2), 523-525 (1991).
94. Lomenick, J. P., Jackson, W. A. & Backeljauw, P. F. Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. J. Perinatol. 24, 397-399 (2004).
95. Trotter, A., Kaestner, M., Pohlandt, F. & Lang, D. Unusual electrocardiogram findings in a preterm infant after fetal tachycardia with hydrops fetalis treated with flecainide. Pediatr. Cardiol. 21, 259-262 (2000).
96. Rasheed, A., Simpson, J. & Rosenthal, E. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia. Heart 89, 470 (2003).
97. Hall, C. M. & Ward Platt, M. P. Neonatal flecainide toxicity following supraventricular tachycardia treatment. Ann. Pharmacother. 37, 1343-1344 (2003).
98. Jaeggi, E. T. & Nii, M. Fetal brady- and tachyarrhythmias: new and accepted diagnostic and treatment methods. Semin. Fetal Neonatal Med. 10, 504-514 (2005).
99. Casey, F. A., McCrindle, B. W., Hamilton, R. M. & Gow, R. M. Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis. Am. Heart J. 133, 302-306 (1997).
100. Copel, J. A., Liang, R. I., Demasio, K., Ozeren, S. & Kleinman, C. S. The clinical significance of the irregular fetal heart rhythm. Am. J. Obstet. Gynecol. 182, 813-819 (2000).
101. Fyfe, D. A., Meyer, K. B. & Case, C. L. Sonographic assessment of fetal cardiac arrhythmias. Semin. Ultrasound CT MR 14, 286-297 (1993).
102. Tan, B.-H. et al. Sudden infant death syndromeassociated mutations in the sodium channel beta subunits. Heart Rhythm doi:10.1016/ j.hrthm.2010.01.032.
103. Rashba, E. J. et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation 97, 451-456 (1998).
104. Tester, D. J. & Ackerman, M. J. Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc. Res. 67, 388-396 (2005).
105. Shim, S. H., Ito, M., Maher, T. & Milunsky, A. Gene sequencing in neonates and infants with the long QT syndrome. Genet. Test. 9, 281-284 (2005).
106. Hofbeck, M., Ulmer, H., Beinder, E., Sieber, E. & Singer, H. Prenatal findings in patients with prolonged QT interval in the neonatal period. Heart 77, 198-204 (1997).
107. Ackerman, M. J. et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286, 2264-2269 (2001).
108. Kominis, I. K., Kornack, T. W., Allred, J. C. & Romalis, M. v. A subfemtotesla multichannel atomic magnetometer. Nature 422, 596-599 (2003).
109. Chan, J., Kumar, S. & Fisk, N. M. First trimester embryo-fetoscopic and ultrasound-guided fetal blood sampling for ex vivo viral transduction of cultured human fetal mesenchymal stem cells. Hum. Reprod. 23, 2427-2437 (2008).
110. Zhao, H., Chen, M., van veen, B. D., Strasburger, J. F. & Wakai, R. T. Simultaneous fetal magnetocardiography and ultrasound/ Doppler imaging. IEEE Trans. Biomed. Eng. 54 (Pt 2), 1167-1171 (2007).
111. Schmidt, K. G., Ulmer, H. E., Silverman, N. H., Kleinman, C. S. & Copel, J. A. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J. Am. Coll. Cardiol. 17, 1360-1366 (1991).
112. Jaeggi, E. T., Hornberger, L. K., Smallhorn, J. F. & Fouron, J. C. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet. Gynecol. 26, 16-21 (2005).
113. Eronen, M. Outcome of fetuses with heart disease diagnosed in utero. Arch. Dis. Child. Fetal Neonatal Ed. 77, F41-F46 (1997).
114. Machado, M. v., Tynan, M. J., Curry, P. v. & Allan, L. D. Fetal complete heart block. Br. Heart J. 60, 512-515 (1988).
115. Gembruch, U., Hansmann, M., Redel, D. A., Bald, R. & Knöpfle, G. Fetal complete heart block: antenatal diagnosis, significance and management. Eur. J. Obstet. Gynecol. Reprod. Biol. 31, 9-22 (1989).
116. Maeno, Y. et al. Clinical course of fetal congenital atrioventricular block in the Japanese population: a multicenter experience. Heart 91, 1075-1079 (2005).